FDA mulls killing Avandia safety study
NEW YORK, April 18 (Reuters) - U.S. regulators are considering ending a safety study on GlaxoSmithKline's diabetes drug Avandia, the Wall Street Journal reported on Sunday, saying the move could also jeopardize the drug's proximity in the U.S market.
posted by (hris @ 4:20 AM
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home